Skip to main content
OpenTrials

Clinical trial condition

Endometrial Cancer

Explore clinical trials studying Endometrial Cancer. Study availability and eligibility vary by location and protocol.

619 public trials 193 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Cancer trial results

Completed

Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

NCT06036836

Conditions
Cutaneous Squamous Cell Carcinoma, Endometrial Cancer, Endometrial Neoplasms, +13 more
Locations
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0643) New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute ( Site 0642) Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey ( Site 0635) New Brunswick, New Jersey, United States
  • Duke Cancer Institute ( Site 0641) Durham, North Carolina, United States
View all 44 locations
View Trial Details
Completed

ONSD as an ICP Marker in vNOTES and TLH

NCT07250178

Conditions
Abnormal Uterine Bleeding, Connective Tissue Diseases, Endometrial Cancer, +23 more
Locations
  • Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital Diyarbakır, Outside of the US, Turkey (Türkiye)
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903

NCT06846099

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +26 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, China
  • Jilin Cancer Hospital Changchun, China
  • Jilin University First Hospital Changchun, China
View all 23 locations
View Trial Details

Related conditions